NEU neuren pharmaceuticals limited

Ann: Investor Presentation, 8 January 2015, page-12

  1. 183 Posts.
    Just getting orphan drug status would be fantastic looking at the small % of applicants that get approved. breakthrough status is a different ball game and highly unlikely given the small sample size but that is not a disaster, just an unexpected bonus if it happens. SP should not be waiting on BT approval as so hard to get
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.26
Change
-0.280(2.23%)
Mkt cap ! $1.525B
Open High Low Value Volume
$12.45 $12.45 $11.88 $6.952M 570.0K

Buyers (Bids)

No. Vol. Price($)
1 231 $12.26
 

Sellers (Offers)

Price($) Vol. No.
$12.32 1979 2
View Market Depth
Last trade - 16.13pm 23/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.